top of page
XenoTherapeutics Executives Spearhead Initial Hurricane Michael Relief Efforts in Panama City, Florida
October 23, 2018
XenoTherapeutics, a life science company developing the first non-human organ transplant solution currently under investigational review by the FDA, announced that company co-founders Paul Holzer, CEO and Jon Adkins, COO, along with a team of former military and first responder volunteers, traveled some 1500 miles from their homes in New Hampshire to deliver emergency aid in the immediate aftermath of Hurricane Michael.
bottom of page